AOD-9604 Dosage Guide

Complete guide to AOD-9604 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Research dosing typically ranges from 250-500mcg daily, often split into morning and afternoon doses. Some protocols use higher doses up to 1mg.

Administration Method

Subcutaneous injection, typically in the abdominal area. Best administered on an empty stomach. Can be combined with exercise for enhanced effects.

Side Effects to Monitor

Generally well-tolerated. May cause headaches, injection site reactions, or temporary lethargy. Does not affect blood glucose like full GH.

Safety Considerations & Risks

Limited long-term human data. Failed to receive FDA approval as an anti-obesity drug. Quality and purity concerns with research-grade products.